Niederle, IM; Woerns, MA; Koch, S et al.
SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) IN RELATION TO THE MELD SCORE AT INITIAL DIAGNOSIS IN A WESTERN COHORT WITH 680 PATIENTSHEPATOLOGY. Bd. 54. 2011 S. 1386A-1386A
Otto, G; Schuchmann, M; Hoppe-Lotichius, M et al.
TACE BEFORE LIVER TRANSPLANTATION: RESPONSE TO BRIDGING PREDICTS HCC RECURRENCETRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 141-141
Pitton, MB; Skowasch, M; Schneider, J et al.
TACE beim HCC im Stadium BCLC-B und –c: DC Bead-TACE versus konventionelle TACEFortschr Röntgenstr. Bd. 183. H. S1. 2011 S. S181
Weiler, N; Thrun, I; Eberlin, M et al.
TACROLIMUS SIDE EFFECTS AFTER LIVER TRANSPLANTATION: IS THERE A DIFFERENCE BETWEEN ONCE DAILY AND TWICE DAILY FORMULATION?TRANSPLANT INTERNATIONAL. Bd. 24. 2011 S. 255-255
Foltys, DB; Kaths, JM; Zimmermann, T et al.
Ten Years of Simultaneous Pancreas-Kidney Transplantation: A Retrospective Single-Center Analysis of Prospectively Obtained DataTRANSPLANTATION PROCEEDINGS. Bd. 43. H. 9. 2011 S. 3267-3269
Zimmermann, T; Hoppe-Lotichius, M; Korner, A et al.
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTRANSPLANT INTERNATIONAL. Bd. 24. H. 11. 2011 S. 1059-1067
Schnitzbauer, AA; Zuelke, C; Graeb, C et al.
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinomaBMC CANCER. Bd. 10. 2010 S. -
Barreiros, AP; Geber, C; Birklein, F et al.
Clinical Symptomatic De Novo Systemic Transthyretin Amyloidosis 9 Years After Domino Liver TransplantationLIVER TRANSPLANTATION. Bd. 16. H. 1. 2010 S. 109-109
Ahmed, D; Niederle, I; Koch, S et al.
COMPARISON OF 8 STAGING SYSTEMS FOR HEPATOCELLULAR CARCINOMA (HCC) IN A WESTERN COHORT WITH 588 PATIENTSHEPATOLOGY. Bd. 52. H. 4. 2010 S. 1170A-1170A
Schmitz, T; Blaickner, M; Schutz, C et al.
Dose calculation in biological samples in a mixed neutron-gamma field at the TRIGA reactor of the University of MainzACTA ONCOLOGICA. Bd. 49. H. 7. 2010 S. 1165-1169
Weiler, N; Thrun, I; Hoppe-Lotichius, M et al.
Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded TrialTRANSPLANTATION. Bd. 90. H. 12. 2010 S. 1562-1566
Pitton, MB; Schneider, J; Schuchmann, G et al.
Klinisch-radiologischer Verlauf nach Transjugulärem Portosystemischem Stent Shunt (TIPS) mit ePTFE-beschichteten StentgraftsIROS Hauptprogramm. 2010 S. S27
Ruth, I; Hoppe-Lotichius, M; Foltys, D et al.
Liver Transplant in Recipients over 65 Years of Age: A Justified Trend?LIVER TRANSPLANTATION. Bd. 16. H. 6. 2010 S. S251-S251
Barreiros, AP; Post, F; Hoppe-Lotichius, M et al.
Liver Transplantation and Combined Liver-Heart Transplantation in Patients with Familial Amyloid Polyneuropathy: A Single-Center ExperienceLIVER TRANSPLANTATION. Bd. 16. H. 3. 2010 S. 314-323
Zimmermann, T; Hoppe-Lotichius, M; Tripkovic, V et al.
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)EUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 21. H. 3. 2010 S. 208-215
Kloeckner, R; Otto, G; Biesterfeld, S et al.
MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular CarcinomaCARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. Bd. 33. H. 3. 2010 S. 532-540
Pitton, MB; Grewatta, M; Bühler, M et al.
Perkutane Pfortaderembolisation versus intraoeprative Pfortaderligatur vor rechtsseitiger Hemihepatektomie: Evaluation des induzierten Volumenzuwachses des linken LeberlappensIROS Hauptprogramm. 2010 S. S26
Otto, G; Duber, C; Hoppe-Lotichius, M et al.
Radiofrequency Ablation as First-Line Treatment in Patients With Early Colorectal Liver Metastases Amenable to SurgeryANNALS OF SURGERY. Bd. 251. H. 5. 2010 S. 796-803
Stangou, AJ; Lobato, L; Zeldenrust, S et al.
Report and recommendations from the 1st International Workshop on the Hereditary Renal Amyloidoses, FAP Symposium, London, 2008AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS. Bd. 17. 2010 S. 125-126
Zimmermann, T; Hoppe-Lotichius, M; Korner, A et al.
ROLE OF THE CYP2D6 POOR METABOLIZER STATUS ON THE FIBROSIS PROGRESSION AFTER LIVER TRANSPLANTATIONTRANSPLANT INTERNATIONAL. Bd. 23. 2010 S. 3-3
Worns, MA; Schuchmann, M; Duber, C et al.
Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib TreatmentONCOLOGY. Bd. 79. H. 1-2. 2010 S. 85-92
Dunschede, F; Will, L; von Langsdorf, C et al.
Treatment of Metachronous and Simultaneous Liver Metastases of Pancreatic CancerEUROPEAN SURGICAL RESEARCH. Bd. 44. H. 3-4. 2010 S. 209-213
Otto, G; Bittinger, F; Hoppe-Lotichius, M et al.
100 PATIENTS WITH LIVER TRANSPLANTATION FOR HCC PRETREATED BY SEQUENTIAL TACE: IMPACT OF TUMOR CHARACTERISTICS ON RECURRENCELIVER TRANSPLANTATION. Bd. 15. H. 7. 2009 S. S252-S252
Heidenhain, C; Puhl, G; Moench, C et al.
Chemokine receptor 532 mutation reduces the risk of acute rejection in liver transplantation.Ann Transplant. Bd. 14. H. 3. 2009 S. 36-44
Barreiros, AP; Walz, R; Geber, C et al.
DE NOVO SYSTEMIC TRANSTHYRETIN AMYLOIDOSIS 9 YEARS AFTER DOMINO LIVER TRANSPLANTATION (DLT)-CASE REPORT AND SCREENING OF LITERATURELIVER TRANSPLANTATION. Bd. 15. H. 7. 2009 S. S203-S203
Nagels, S; Hampel, G; Kratz, JV et al.
Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT.Appl Radiat Isot. Bd. 67. H. 7-8 Suppl. 2009 S. S242-6
Barreiros, AP; Sprinzl, M; Rosset, S et al.
EGF and HGF levels are increased during active HBV infection and enhance survival signaling through extracellular matrix interactions in primary human hepatocytesInt J Cancer. Bd. 124. H. 1. 2009 S. 120-9
Klein, A; Otto, G; Krämer, I
Impact of a pharmaceutical care program on liver transplant patients' compliance with immunosuppressive medication: a prospective, randomized, controlled trial using electronic monitoringTransplantation. Bd. 87. H. 6. 2009 S. 839-47
Hampel, G; Wortmann, B; Blaickner, M et al.
Irradiation facility at the TRIGA Mainz for treatment of liver metastases.Appl Radiat Isot. Bd. 67. H. 7-8 Suppl. 2009 S. S238-41
Barreiros, AP; Post, F; Hoppe-Lotichius, M et al.
LIVER TRANSPLANTATION IN PATIENTS WITH FAMILIAL AMYLOID (FAP): COMPARISON OF DIFFERENT TRANSTHYRETIN MUTATIONSLIVER TRANSPLANTATION. Bd. 15. H. 7. 2009 S. S265-S265
Kloeckner, R; Otto, G; Biesterfeld, S et al.
MDCT Versus MRI Assessment of Tumor Response After Transarterial Chemoembolization for the Treatment of Hepatocellular CarcinomaCardiovasc Intervent Radiol. 2009 S. Oct 22 Epub
Pitton, MB; Kloeckner, R; Herber, S et al.
MRI versus 64-row MDCT for diagnosis of hepatocellular carcinomaWorld J Gastroenterol. Bd. 15. H. 48. 2009 S. 6044-51
Gelber, C; Barreiros, AP; Walz, R et al.
NEUROLOGICAL FOLLOW-UP IN PATIENTS AFTER DOMINO-LIVER TRANSPLANTATIONJOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. Bd. 14. 2009 S. 55-55
Foltys, D; Linkermann, A; Heumann, A et al.
Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case reportTransplant Proc. Bd. 41. 2009 S. 2639-2642
Otto, G; Fassbinder, W; Blettner, M et al.
Organspende in Deutschland: Kritische SituationDtsch Arztebl. Bd. 106. H. 5. 2009 S. 182-184
Zimmermann, T; Tripkovic, V; Hoppe-Lotichius, M et al.
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS (PTLD) IN ADULT LIVER TRANSPLANTED PATIENTS WITH IMMUNOLOGICAL DISEASESLIVER TRANSPLANTATION. Bd. 15. H. 7. 2009 S. S198-S198
Greif-Higer, G; Otto, G; Beutel, ME
Psychic long-term disorders following after High urgency transformation of Liver in a case of acute Liver failurePSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE. Bd. 59. H. 2. 2009 S. 103-103
Zimmermann, T; Otto, C; Hoppe-Lotichius, M et al.
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantationTransplant Proc. Bd. 41. H. 6. 2009 S. 2549-56
Wörns, MA; Weinmann, A; Pfingst, K et al.
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.J Clin Gastroenterol. Bd. 43. H. 5. 2009 S. 489-495
Barreiros, AP; Otto, G; Ignee, A et al.
Sonographic signs of amyloidosisEndoscopy. Bd. 47. H. 8. 2009 S. 731-9
Perz, JB; Hegenbart, U; Kroeger, N et al.
Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.Haematologica. Bd. 94. H. 4. 2009 S. 594-6
Otto, G; Hoppe-Lotichius, M; Laubert-Reh, D et al.
TRANSARTERIAL CHEMOEMBOLISATION BEFORE LIVER TRANSPLANTATION: WHO DROPS OUT?TRANSPLANT INTERNATIONAL. Bd. 22. 2009 S. 10-11
Foltys, DB; Heise, M; Hoppe-Lotichius, M et al.
WASTING KIDNEY GRAFTSTRANSPLANT INTERNATIONAL. Bd. 22. 2009 S. 100-101
Otto, G
16th Congress of the German Transplantation Society. PrefaceTransplant Proc. Bd. 40. H. 4. 2008 S. 887
Zimmermann, T; Kashyap, A; Hartmann, U et al.
Cloning and characterization of the promoter of Hugl-2, the human homologue of Drosophila lethal giant larvae (lgl) polarity gene.Biochem Biophys Res Commun. Bd. 366. H. 4. 2008 S. 1067-73
Herber, S; Biesterfeld, S; Franz, U et al.
Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.Cardiovasc Intervent Radiol. Bd. 31. H. 4. 2008 S. 768-77
Wörns, MA; Teufel, A; Kanzler, S et al.
Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.Am J Gastroenterol. Bd. 103. H. 1. 2008 S. 138-46
Kaiser, GM; Sotiropoulos, GC; Jauch, KW et al.
Liver transplantation for hilar cholangiocarcinoma: a German surveyTransplant Proc. Bd. 40. H. 9. 2008 S. 3191-3
Kloeckner, R; Otto, G; Herber, S et al.
MRI versus 64-row MDCT for diagnosis of HCCEur Radiol. Bd. 18. H. S1. 2008 S. 309
Greif-Higer, G; Wandel, E; Otto, G et al.
Psychological conflicts between relatives during the long-term course after successful living organ donation.Transplant Proc. Bd. 40. H. 4. 2008 S. 902-6